$1,303,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain"
You can find more data on corporate lobbying on Quiver Quantitative.
BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BDX Insider Trading Activity
BDX insiders have traded $BDX stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- ROLAND GOETTE (EVP and President, EMEA) has made 0 purchases and 2 sales selling 5,121 shares for an estimated $1,130,528.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 3,914 shares for an estimated $869,504.
- SHANA CAROL NEAL (EVP and Chief People Officer) has made 0 purchases and 3 sales selling 2,575 shares for an estimated $594,550.
- RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
- DAVID SHAN (EVP and Chief ISC Officer) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $450,375.
- JEFFREY WILLIAM HENDERSON purchased 1,500 shares for an estimated $350,430
- BERTRAM L SCOTT sold 700 shares for an estimated $159,593
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BDX Hedge Fund Activity
We have seen 664 institutional investors add shares of BDX stock to their portfolio, and 747 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,219,317 shares (+36.1%) to their portfolio in Q4 2024, for an estimated $730,366,447
- KOVITZ INVESTMENT GROUP PARTNERS, LLC added 2,722,829 shares (+392.4%) to their portfolio in Q4 2024, for an estimated $617,728,215
- BLACKROCK, INC. added 1,711,450 shares (+7.7%) to their portfolio in Q4 2024, for an estimated $388,276,661
- CITADEL ADVISORS LLC added 1,398,984 shares (+376.2%) to their portfolio in Q4 2024, for an estimated $317,387,500
- BANK OF NEW YORK MELLON CORP removed 1,308,118 shares (-28.6%) from their portfolio in Q4 2024, for an estimated $296,772,730
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,251,742 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $283,982,707
- BANK OF AMERICA CORP /DE/ added 1,098,633 shares (+77.8%) to their portfolio in Q4 2024, for an estimated $249,246,868
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 12/18/2024
To track analyst ratings and price targets for BDX, check out Quiver Quantitative's $BDX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
